Wellcome Trust continued to hold its position in shares of Castlight Health Inc (NASDAQ:CSLT) during the fourth quarter, according to its most recent 13F filing with the SEC. The hedge fund owned 6,568,646 shares of the company’s stock at the end of the fourth quarter. Castlight Health accounts for approximately 0.6% of Wellcome Trust’s investment portfolio, making the stock its 28th largest position. Wellcome Trust owned 12.02% of Castlight Health worth $27,982,000 at the end of the most recent quarter.

Castlight Health Inc (NASDAQ:CSLT) opened at 3.64 on Friday. The stock’s 50 day moving average is $3.98 and its 200-day moving average is $5.09. The firm’s market capitalization is $344.50 million. Castlight Health Inc has a 1-year low of $3.16 and a 1-year high of $10.36.

Castlight Health (NASDAQ:CSLT) last announced its earnings results on Wednesday, November 4th. The company reported ($0.17) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.17). The firm had revenue of $19.50 million for the quarter, compared to the consensus estimate of $19.42 million. During the same period in the prior year, the business earned ($0.18) EPS. Castlight Health’s quarterly revenue was up 59.8% on a year-over-year basis. Analysts forecast that Castlight Health Inc will post ($0.70) EPS for the current year.

A number of equities analysts recently weighed in on CSLT shares. First Analysis raised shares of Castlight Health from an “equal weight” rating to an “overweight” rating and set a $8.00 target price for the company in a research note on Friday, October 9th. Stifel Nicolaus upped their target price on shares of Castlight Health from $7.00 to $12.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. FBR & Co. started coverage on shares of Castlight Health in a research note on Wednesday, November 18th. They issued a “market perform” rating and a $5.00 target price for the company. Topeka Capital Markets started coverage on shares of Castlight Health in a research note on Wednesday, December 16th. They issued a “buy” rating and a $6.50 target price for the company. Finally, Leerink Swann lowered shares of Castlight Health from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $14.00 to $5.00 in a research note on Thursday, November 5th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Castlight Health currently has a consensus rating of “Buy” and an average price target of $7.71.

In related news, major shareholder Associates V. Lp Venrock purchased 350,000 shares of the firm’s stock in a transaction on Tuesday, November 10th. The stock was purchased at an average cost of $3.77 per share, with a total value of $1,319,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John Mccracken sold 23,493 shares of Castlight Health stock in a transaction on Wednesday, November 18th. The shares were sold at an average price of $3.87, for a total transaction of $90,917.91. Following the completion of the sale, the senior vice president now directly owns 56,507 shares of the company’s stock, valued at $218,682.09. The disclosure for this sale can be found here.

Castlight Health, Inc. is a provider of cloud-based software that enables enterprises to understand and manage health care spending as a business investment, and help employees and their families make medical decisions. The Company’s Enterprise Healthcare Cloud provides information to its employees, implementing technology-enabled benefit designs and integrating systems and applications. The Company deploys consumer-oriented applications that deliver employee engagement and enable employers to integrate benefit programs into one platform available to employees and their families. The Company’s Enterprise Healthcare Cloud offering transforms data into transparent and useful information. This data include external data, which it obtains from sources, such as health care providers, insurance companies, governmental agencies and quality-monitoring organizations, as well as internal data generated through the usage of its applications.

12 Month Chart for NASDAQ:CSLT

Receive News & Ratings for Castlight Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.